P

Precede Biosciences

Epigenomic liquid biopsy for cancer.

Associate Director - Regulatory Affairs, IVD

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timeCambridge, MA, USA

About the Job

Requirements

  • A bachelor's degree in life sciences, engineering, or a related field.
  • A minimum of 8 years of regulatory affairs experience in medical devices, including substantial experience with in vitro diagnostic devices and increasing responsibility for regulatory strategy and submissions.
  • A demonstrated record of leading and authoring substantial portions of FDA in vitro diagnostic submissions, including direct experience with at least one major premarket pathway such as 510(k), De Novo, or PMA.
  • Strong knowledge of United States and European Union in vitro diagnostic requirements, design and development controls, risk management, and quality system expectations, with the ability to apply requirements to complex scientific and technical questions.
  • Experience with molecular diagnostics, next-generation sequencing-based assays, or other complex diagnostics combining laboratory processes, software, algorithms, and bioinformatics.
  • Ability to interpret analytical and clinical performance data and determine whether the evidence supports an intended use, claim, or regulatory position.
  • Technical writing skills and the ability to explain complex issues clearly to regulators, partners, scientists, and senior leaders.
  • Sound judgment and the ability to balance strategic direction with hands-on execution and manage multiple priorities with limited oversight.

Responsibilities

  • Develop and execute United States and global in vitro diagnostic regulatory strategies from early development through commercialization, including pathway, intended use, claims, evidence, and sequencing of agency interactions.
  • Author, compile, and drive submissions and responses, including FDA Pre-Submissions, Investigational Device Exemptions, 510(k)s, De Novo requests, Premarket Approval applications and supplements, and relevant international technical documentation supporting in vitro diagnostic regulation CE marking.
  • Lead interactions with the FDA and other health authorities or notified bodies, prepare teams for meetings, and convert agency feedback into decisions and development plans.
  • Serve as the regulatory lead for biopharma collaborations, aligning diagnostic and therapeutic development plans, clinical trial assay readiness, evidence generation, filing strategy, and labeling considerations.
  • Partner with assay development, computational biology, laboratory operations, quality, and program teams to define analytical and clinical performance studies supporting intended use and proposed claims.
  • Critically review protocols, reports, and technical documentation, including pre-analytical variables, specimen stability, analytical validation, software verification and validation, clinical performance, and bridging studies, to ensure conclusions are accurate and well supported.
  • Define regulatory requirements for in vitro diagnostic products, including software, algorithms, and bioinformatics pipelines used in regulated products or in data supporting diagnostic and therapeutic submissions.
  • Contribute to design and development controls, risk management, document control, and audit and inspection readiness in alignment with the FDA Quality Management System Regulation, ISO 13485, ISO 14971, and CLIA and CAP requirements as applicable.
  • Evaluate product, design, software, manufacturing, and labeling changes for regulatory impact, and review product communications and Research Use Only claims for compliance.
  • Interpret evolving requirements, identify risks early, and recommend practical, science-based paths that protect patients, program objectives, and business priorities.

Desired Qualifications

  • Companion diagnostic development, particularly oncology programs, and coordination of diagnostic and therapeutic regulatory strategies from clinical development through approval.
  • Liquid biopsy, epigenomics, oncology diagnostics, or biomarker-driven drug development.
  • Global in vitro diagnostic registrations, including familiarity with the European Union In Vitro Diagnostic Medical Devices Regulation and technical documentation expectations.
  • Regulatory oversight of software and bioinformatics lifecycle documentation for complex diagnostic products.
  • An advanced scientific degree or Regulatory Affairs Certification.

About the Company

Precede Biosciences

Epigenomic liquid biopsy for cancer.

Precede Biosciences uses a blood test to read epigenomic signals in plasma. It analyzes circulating chromatin and the DNA methylome from a single milliliter of blood to determine the activation status of about 20,000 gene promoters and 1 million gene enhancers, providing a transcriptional biology view of disease. The platform supports drug development through Research Use Only partnerships with biopharmaceutical companies and academia, and aims to develop clinical blood-based tests that can replace invasive tissue biopsies for guiding precision medicines in cancers such as breast, lung, prostate, and colorectal. Unlike purely genomic tests, this approach focuses on epigenomic regulation to reveal disease biology, treatment response, and resistance. The company seeks to help identify therapeutic targets and mechanisms driving outcomes, with a goal of accelerating biomarker discovery and enabling non-invasive, dynamic insights into cancer biology.

Company size
51-200
Company stage
Debt Financing
Total funding
$140.5M
Headquarters
Boston, MA
Founded
2021

Recently Posted Jobs

Explore more opportunities at Precede Biosciences

See more jobs